Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) Non Operating Income (2023 - 2026)

Adagio Medical Holdings has reported Non Operating Income over the past 4 years, most recently at $70000.0 for Q1 2026.

  • Quarterly Non Operating Income rose 122.15% to $70000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Mar 2026, down 82.22% year-over-year, with the annual reading at -$3.2 million for FY2025, 136.64% down from the prior year.
  • Non Operating Income was $70000.0 for Q1 2026 at Adagio Medical Holdings, down from $662000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $8.0 million in Q3 2024 and troughed at -$8.5 million in Q4 2023.
  • The 4-year median for Non Operating Income is $41000.0 (2025), against an average of $137300.0.
  • The largest YoY upside for Non Operating Income was 15300.0% in 2025 against a maximum downside of 139.65% in 2025.
  • A 4-year view of Non Operating Income shows it stood at -$8.5 million in 2023, then soared by 194.09% to $8.0 million in 2024, then plummeted by 91.76% to $662000.0 in 2025, then crashed by 89.43% to $70000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Non Operating Income are $70000.0 (Q1 2026), $662000.0 (Q4 2025), and $12000.0 (Q3 2025).